Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include produ…
$197.88-1.80%
报价 2026-11-06
市值
$308.42B
EV
$298.08B
PE (TTM)
22.4x
预期 PE (FY2026)
23.7x
52 周区间距高点 -6.3%
$147.81$211.28
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 8.22 → 9.06（1.1x） | 21.8 |
| FY+32028-12 | 1.1x | 8.22 → 9.88（1.2x） | 20.0 |
毛利率 67% · TTM 收入 $43138M · 基数 EPS 8.22（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PMPhilip Morris International Inc. | $308.42B | -1.8% | +7.2% | 68.7% | 22.4x | 17.1x | 28.9x | |
| KOThe Coca-Cola Company | $411.56B | -0.1% | +1.7% | 63.2% | 24.7x | 19.2x | 77.7x | |
| PGThe Procter & Gamble Company | $383.36B | -1.0% | +2.8% | 49.8% | 21.2x | 15.3x | 26.8x | |
| PEPPepsiCo, Inc. | $192.61B | -1.0% | +6.0% | 54.4% | 25.0x | 15.9x | 25.1x | |
| BUDAnheuser-Busch InBev SA/NV | $167.68B | -1.5% | – | 56.3% | 13.1x | 6.5x | – | |
| ULUnilever PLC | $144.18B | -2.5% | – | 100% | 26.4x | 17.8x | – | |
| BTIBritish American Tobacco p.l.c. | $134.35B | -3.5% | – | 59.1% | 12.2x | 10.0x | – | |
| MOAltria Group, Inc. | $126.62B | -1.9% | +3.0% | 71.3% | 15.6x | 12.3x | 14.8x | |
| RLXRLX Technology Inc. | $1.97B | -0.6% | – | 39% | 19.6x | 37.1x | – | |
| 同行中位数 | – | – | +2.9% | 57.7% | 20.4x | 15.6x | 25.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.44B | $11.19B | $10.15B | $10.36B | $10.85B | $10.14B | $9.3B | $9.71B |
| Gross Margin | 68.7% | 68.4% | 68.1% | 65.6% | 67.8% | 67.7% | 67.3% | 64.7% |
| Operating Margin | 42.5% | 40.5% | 38.4% | 32.6% | 39.3% | 37% | 38.1% | 33.6% |
| Net Income | $3.31B | $2.82B | $2.44B | $2.14B | $3.48B | $3.04B | $2.69B | $-579M |
| Diluted EPS | 2.12 | 1.8 | 1.56 | 1.37 | 2.23 | 1.95 | 1.72 | -0.37 |
| Operating Cash Flow | $5.35B | $5.49B | $-399M | $4.71B | $4.46B | $3.41B | $-350M | $4B |
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。